The Trump Administration last week moved to reclassify marijuana as a less dangerous drug. Is the goal to reduce America’s collective IQ? The main practical effect of the Justice Department’s ...

Donald Trump has ordered a sweeping rethink of US drug policy in Washington, signing an executive order to accelerate research into psychedelic medicines and directing his administration to reschedule ...

(NEXSTAR) – As was roughly anticipated, the Trump administration has moved to partially reclassify marijuana, announcing on Thursday that state-licensed medical marijuana will now be considered a less ...

ROCHESTER – The Justice Department announced plans this week that could ease restrictions on state-licensed medical marijuana. CannaMetrix on Jefferson Road tests the potency of cannabis products. The ...

Washington — The Justice Department announced Thursday that it has issued an order rescheduling certain marijuana products to a lower drug classification, while moving to expedite the process to ...

The Trump administration is reclassifying marijuana this week, according to an Axios report. In December, U.S. President Donald Trump signed an executive order to ease federal restrictions on ...

CHICAGO (WLS) -- A prominent lab used by prosecutors for marijuana DUI testing in Chicago and the suburbs is no longer doing human testing but the fallout surrounding the flawed results continues.

The Trump administration on Thursday announced that it was loosening restrictions on marijuana to boost medical research, days after President Donald Trump appeared to express frustration with the ...

The rule moves F.D.A.-approved marijuana and state-regulated marijuana out of the Schedule I category, which includes drugs like heroin. By Devlin Barrett Reporting from Washington The Justice ...

The Trump administration moved to boost medical research into marijuana Thursday by reducing federal regulation of the drug. The expanded access for researchers will apply only to products approved by ...

The U.S. administration reclassified state-licensed or FDA approved marijuana products from a Schedule I to a Schedule III drug. This reclassification does not immediately change marijuana's legal ...